LIQUIVISC Eye gel Ref.[49990] Active ingredients: Carbomer

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Laboratoires Thea, 12 rue Louis Blรฉriot, Z.I.du Brรฉzet, 63017 Clermont-Ferrand Cedex 2, France

4.1. Therapeutic indications

Symptomatic treatment of dry eye syndrome.

4.2. Posology and method of administration

Ocular use.

Adults (including the elderly)

Instil one drop of the gel into the inferior conjunctival cul-de-sac 1 to 4 times daily according to the degree of ocular trouble.

Children and adolescents aged to 18 years

The safety and efficacy of LIQUIVISC 2.5 mg/g eye gel in children and adolescents at the posology recommended in adults has been established by clinical experience, but no clinical trial data are available.

After instillation, the bottle should be stored vertically with the dropper downwards to facilitate the formation of drops when next used.

Do not touch the eye with the dropper tip. Replace the cap after use.

4.9. Overdose

Any ocular overdose or oral intake that could occur is of no clinical relevance.

6.3. Shelf life

Shelf life prior to opening: 30 months.

In-use shelf life: 4 weeks.

6.4. Special precautions for storage

Do not store above 25ยฐC. Store container in the outer carton, in order to protect from light.

6.5. Nature and contents of container

10 g in 10 m1 bottle (PE) with dropper (PE).

6.6. Special precautions for disposal and other handling

No special requirements.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.